These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 27422608)
1. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy. Kikuchi S; Kanoh D; Sato S; Sakurai Y; Suzuki M; Nakamura H J Control Release; 2016 Sep; 237():160-7. PubMed ID: 27422608 [TBL] [Abstract][Full Text] [Related]
2. Cyclic RGD-Functionalized Kawai K; Nishimura K; Okada S; Sato S; Suzuki M; Takata T; Nakamura H Mol Pharm; 2020 Oct; 17(10):3740-3747. PubMed ID: 32845640 [TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model. Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337 [TBL] [Abstract][Full Text] [Related]
4. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy. Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186 [TBL] [Abstract][Full Text] [Related]
5. Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy. Okada S; Nishimura K; Ainaya Q; Shiraishi K; Anufriev SA; Sivaev IB; Sakurai Y; Suzuki M; Yokoyama M; Nakamura H Mol Pharm; 2023 Dec; 20(12):6311-6318. PubMed ID: 37909734 [TBL] [Abstract][Full Text] [Related]
6. Carrier proteins-based boron delivery to tumor. Kikuchi S; Sato S; Nakamura H Appl Radiat Isot; 2020 Mar; 157():109011. PubMed ID: 31889673 [TBL] [Abstract][Full Text] [Related]
7. Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy. Tachikawa S; Miyoshi T; Koganei H; El-Zaria ME; ViƱas C; Suzuki M; Ono K; Nakamura H Chem Commun (Camb); 2014 Oct; 50(82):12325-8. PubMed ID: 25182569 [TBL] [Abstract][Full Text] [Related]
8. Boron Neutron Capture Therapy (BNCT) Mediated by Maleimide-Functionalized Monti Hughes A; Goldfinger JA; Palmieri MA; Ramos P; Santa Cruz IS; De Leo L; Garabalino MA; Thorp SI; Curotto P; Pozzi ECC; Kawai K; Sato S; Itoiz ME; Trivillin VA; Guidobono JS; Nakamura H; Schwint AE Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888170 [TBL] [Abstract][Full Text] [Related]
9. Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy. Popova T; Dymova MA; Koroleva LS; Zakharova OD; Lisitskiy VA; Raskolupova VI; Sycheva T; Taskaev S; Silnikov VN; Godovikova TS Molecules; 2021 Oct; 26(21):. PubMed ID: 34770947 [TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas. Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173 [TBL] [Abstract][Full Text] [Related]
11. Design of S-S bond containing maleimide-conjugated closo-dodecaborate (SSMID): identification of unique modification sites on albumin and investigation of intracellular uptake. Ishii S; Sato S; Asami H; Hasegawa T; Kohno JY; Nakamura H Org Biomol Chem; 2019 Jun; 17(22):5496-5499. PubMed ID: 30976763 [TBL] [